NRBT yields 10000.00% · JNJ yields 2.13%● Live data
📍 NRBT pulled ahead of the other in Year 1
Combined, NRBT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NRBT + JNJ for your $10,000?
Novus Robotics Inc., through its subsidiary, D&R Technology Inc., engages in engineering, designing, manufacturing, and selling automated tube processing solutions for the automotive industry worldwide. The company designs and installs retrofits to existing automated systems, as well as offers spare parts, maintenance, and repair and production support services to automotive tier I businesses and their suppliers. Its products include seat frame systems, IP tube systems, and integrated bend-weld systems. The company also provides value added services, including system upgrades and rebuilds, control system upgrades, tooling retrofits, pre-production and prototyping requirements, training, equipment relocation and redeployment, systems audit, manufacturing consulting, and project management services. The company offers its products to automotive seating manufacturers and manufacturers of tubing products. Novus Robotics Inc. was founded in 2004 and is based in Mississauga, Canada.
Full NRBT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.